ARQT Q3 2021 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$192,000

Operating Income

-$57M

Net Income

-$57M

EPS (Diluted)

$-1.14

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$41M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$387M

Total Liabilities

$24M

Stockholders' Equity

$363M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$192,000	$0	—
Operating Income	-$57M	-$38M	-49.0%
Net Income	-$57M	-$38M	-49.1%